JP Patent

JP7525264B2 — アトピー性皮膚炎の治療及び原薬の安定性を向上するための製剤、方法、キット、及び剤形

Assigned to リベルタス バイオ，インコーポレイティド · Expires 2024-07-30 · 2y expired

What this patent protects

Patent listed against Colcrys.

Drugs covered by this patent

Patent Metadata

Patent number
JP7525264B2
Jurisdiction
JP
Classification
—
Expires
2024-07-30
Drug substance claim
No
Drug product claim
No
Assignee
リベルタス バイオ，インコーポレイティド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.